Neukio Biotherapeutics
PrivateLast Round
Series A
Sep 2, 2022
Total Funding Raised
$90M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neukio Biotherapeutics operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in September 2022.
Neukio Biotherapeutics is a biotechnology company that develops iPSC-derived cell technology platforms and next-generation off-the-shelf immune cell products for treating solid tumors and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neukio Biotherapeutics Comparables
Compare Neukio Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellOrigin Biotech | 89% | |
| Therabest | 88% | |
| Shoreline Biosciences | 84% |
For institutional investors. Book with your work email.
Neukio Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 2, 2022 | ||||
| Angel | Jul 29, 2021 |
For institutional investors. Book with your work email.
Neukio Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series A |
| IDG Capital | Angel, Series A |
| Lilly Asia Ventures | Series A, Angel |
| Sherpa Healthcare Partners | Series A |
| CD Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 68% MoM, reaching 2.4K.
- Apr 5, 2026
Monthly visitors increased 137% MoM.
For institutional investors. Book with your work email.
Neukio Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neukio Biotherapeutics's valuation, stock price, and market status.
Is Neukio Biotherapeutics a public or private company?
Neukio Biotherapeutics is a private company.
What is the current stock price of Neukio Biotherapeutics?
Neukio Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Neukio Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neukio Biotherapeutics worth (valuation)?
Valuation information for Neukio Biotherapeutics is not publicly available.
Can I buy Neukio Biotherapeutics stock?
Neukio Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neukio Biotherapeutics's last funding round?
Neukio Biotherapeutics's most recent funding round was Series A on September 2, 2022.
Who are the main investors in Neukio Biotherapeutics?
Key investors in Neukio Biotherapeutics include Lilly Asia Ventures, CD Capital.
Will Neukio Biotherapeutics IPO soon?
No public IPO plans have been announced for Neukio Biotherapeutics.
How can I track Neukio Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Neukio Biotherapeutics's shares on secondary markets.